210 related articles for article (PubMed ID: 21152392)
1. Adjusting mortality for loss to follow-up: analysis of five ART programmes in sub-Saharan Africa.
Brinkhof MW; Spycher BD; Yiannoutsos C; Weigel R; Wood R; Messou E; Boulle A; Egger M; Sterne JA;
PLoS One; 2010 Nov; 5(11):e14149. PubMed ID: 21152392
[TBL] [Abstract][Full Text] [Related]
2. Prognosis of patients with HIV-1 infection starting antiretroviral therapy in sub-Saharan Africa: a collaborative analysis of scale-up programmes.
May M; Boulle A; Phiri S; Messou E; Myer L; Wood R; Keiser O; Sterne JA; Dabis F; Egger M;
Lancet; 2010 Aug; 376(9739):449-57. PubMed ID: 20638120
[TBL] [Abstract][Full Text] [Related]
3. Mortality of HIV-infected patients starting antiretroviral therapy in sub-Saharan Africa: comparison with HIV-unrelated mortality.
Brinkhof MW; Boulle A; Weigel R; Messou E; Mathers C; Orrell C; Dabis F; Pascoe M; Egger M;
PLoS Med; 2009 Apr; 6(4):e1000066. PubMed ID: 19399157
[TBL] [Abstract][Full Text] [Related]
4. Correcting mortality for loss to follow-up: a nomogram applied to antiretroviral treatment programmes in sub-Saharan Africa.
Egger M; Spycher BD; Sidle J; Weigel R; Geng EH; Fox MP; MacPhail P; van Cutsem G; Messou E; Wood R; Nash D; Pascoe M; Dickinson D; Etard JF; McIntyre JA; Brinkhof MW;
PLoS Med; 2011 Jan; 8(1):e1000390. PubMed ID: 21267057
[TBL] [Abstract][Full Text] [Related]
5. Scaling up antiretroviral therapy for HIV-infected children in Côte d'Ivoire: determinants of survival and loss to programme.
Anaky MF; Duvignac J; Wemin L; Kouakoussui A; Karcher S; Touré S; Seyler C; Fassinou P; Dabis F; N'Dri-Yoman T; Anglaret X; Leroy V
Bull World Health Organ; 2010 Jul; 88(7):490-9. PubMed ID: 20616968
[TBL] [Abstract][Full Text] [Related]
6. Retention and mortality on antiretroviral therapy in sub-Saharan Africa: collaborative analyses of HIV treatment programmes.
Haas AD; Zaniewski E; Anderegg N; Ford N; Fox MP; Vinikoor M; Dabis F; Nash D; Sinayobye JD; Niyongabo T; Tanon A; Poda A; Adedimeji AA; Edmonds A; Davies MA; Egger M;
J Int AIDS Soc; 2018 Feb; 21(2):. PubMed ID: 29479867
[TBL] [Abstract][Full Text] [Related]
7. Loss to programme between HIV diagnosis and initiation of antiretroviral therapy in sub-Saharan Africa: systematic review and meta-analysis.
Mugglin C; Estill J; Wandeler G; Bender N; Egger M; Gsponer T; Keiser O;
Trop Med Int Health; 2012 Dec; 17(12):1509-20. PubMed ID: 22994151
[TBL] [Abstract][Full Text] [Related]
8. Outcomes of HIV-positive patients lost to follow-up in African treatment programmes.
Zürcher K; Mooser A; Anderegg N; Tymejczyk O; Couvillon MJ; Nash D; Egger M;
Trop Med Int Health; 2017 Apr; 22(4):375-387. PubMed ID: 28102610
[TBL] [Abstract][Full Text] [Related]
9. Gender differences in survival among adult patients starting antiretroviral therapy in South Africa: a multicentre cohort study.
Cornell M; Schomaker M; Garone DB; Giddy J; Hoffmann CJ; Lessells R; Maskew M; Prozesky H; Wood R; Johnson LF; Egger M; Boulle A; Myer L;
PLoS Med; 2012; 9(9):e1001304. PubMed ID: 22973181
[TBL] [Abstract][Full Text] [Related]
10. AIDS and non-AIDS morbidity and mortality across the spectrum of CD4 cell counts in HIV-infected adults before starting antiretroviral therapy in Cote d'Ivoire.
Anglaret X; Minga A; Gabillard D; Ouassa T; Messou E; Morris B; Traore M; Coulibaly A; Freedberg KA; Lewden C; Ménan H; Abo Y; Dakoury-Dogbo N; Toure S; Seyler C;
Clin Infect Dis; 2012 Mar; 54(5):714-23. PubMed ID: 22173233
[TBL] [Abstract][Full Text] [Related]
11. Outcomes of antiretroviral treatment in programmes with and without routine viral load monitoring in Southern Africa.
Keiser O; Chi BH; Gsponer T; Boulle A; Orrell C; Phiri S; Maxwell N; Maskew M; Prozesky H; Fox MP; Westfall A; Egger M;
AIDS; 2011 Sep; 25(14):1761-9. PubMed ID: 21681057
[TBL] [Abstract][Full Text] [Related]
12. How have ART treatment programmes changed the patterns of excess mortality in people living with HIV? Estimates from four countries in East and Southern Africa.
Slaymaker E; Todd J; Marston M; Calvert C; Michael D; Nakiyingi-Miiro J; Crampin A; Lutalo T; Herbst K; Zaba B
Glob Health Action; 2014; 7():22789. PubMed ID: 24762982
[TBL] [Abstract][Full Text] [Related]
13. Excess mortality associated with mental illness in people living with HIV in Cape Town, South Africa: a cohort study using linked electronic health records.
Haas AD; Ruffieux Y; van den Heuvel LL; Lund C; Boulle A; Euvrard J; Orrell C; Prozesky HW; Tiffin N; Lovero KL; Tlali M; Davies MA; Wainberg ML;
Lancet Glob Health; 2020 Oct; 8(10):e1326-e1334. PubMed ID: 32971055
[TBL] [Abstract][Full Text] [Related]
14. Temporal trends in mortality and loss to follow-up among children enrolled in Côte d'Ivoire's national antiretroviral therapy program.
Auld AF; Tuho MZ; Ekra KA; Shiraishi RW; Mohamed F; Kouakou JS; Ettiègne-Traoré V; Sabatier J; Essombo J; Rivadeneira ED; Adjorlolo-Johnson G; Marlink R; Ellerbrock TV
Pediatr Infect Dis J; 2014 Nov; 33(11):1134-40. PubMed ID: 25093975
[TBL] [Abstract][Full Text] [Related]
15. Distribution of advanced HIV disease from three high HIV prevalence settings in Sub-Saharan Africa: a secondary analysis data from three population-based cross-sectional surveys in Eshowe (South Africa), Ndhiwa (Kenya) and Chiradzulu (Malawi).
Chihana ML; Huerga H; Van Cutsem G; Ellman T; Goemaere E; Wanjala S; Masiku C; Szumilin E; Etard JF; Maman D; Davies MA
Glob Health Action; 2019; 12(1):1679472. PubMed ID: 31679482
[No Abstract] [Full Text] [Related]
16. Association between older age and adverse outcomes on antiretroviral therapy: a cohort analysis of programme data from nine countries.
Greig J; Casas EC; O'Brien DP; Mills EJ; Ford N
AIDS; 2012 Jul; 26 Suppl 1():S31-7. PubMed ID: 22781173
[TBL] [Abstract][Full Text] [Related]
17. Determinants of time to antiretroviral treatment initiation and subsequent mortality on treatment in a cohort in rural northern Malawi.
Brown JP; Ngwira B; Tafatatha T; Crampin AC; French N; Koole O
AIDS Res Ther; 2016; 13():24. PubMed ID: 27398087
[TBL] [Abstract][Full Text] [Related]
18. Mortality in patients with HIV-1 infection starting antiretroviral therapy in South Africa, Europe, or North America: a collaborative analysis of prospective studies.
Boulle A; Schomaker M; May MT; Hogg RS; Shepherd BE; Monge S; Keiser O; Lampe FC; Giddy J; Ndirangu J; Garone D; Fox M; Ingle SM; Reiss P; Dabis F; Costagliola D; Castagna A; Ehren K; Campbell C; Gill MJ; Saag M; Justice AC; Guest J; Crane HM; Egger M; Sterne JA
PLoS Med; 2014 Sep; 11(9):e1001718. PubMed ID: 25203931
[TBL] [Abstract][Full Text] [Related]
19. Correcting for mortality among patients lost to follow up on antiretroviral therapy in South Africa: a cohort analysis.
Van Cutsem G; Ford N; Hildebrand K; Goemaere E; Mathee S; Abrahams M; Coetzee D; Boulle A
PLoS One; 2011 Feb; 6(2):e14684. PubMed ID: 21379378
[TBL] [Abstract][Full Text] [Related]
20. Variations in the characteristics and outcomes of children living with HIV following universal ART in sub-Saharan Africa (2006-17): a retrospective cohort study.
Iyun V; Technau KG; Vinikoor M; Yotebieng M; Vreeman R; Abuogi L; Desmonde S; Edmonds A; Amorissani-Folquet M; Davies MA;
Lancet HIV; 2021 Jun; 8(6):e353-e362. PubMed ID: 33932330
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
